TRAJENTA
TRAJENTA
Approved
DIN Number
02370921
Drug Class
Human
Market Date
Sep 13, 2011
Company
HC
boehringer ingelheim (canada) ltd ltee
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02370921
AIG Number0152946001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BH05 LINAGLIPTIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:20.05
Health Canada Classification
ACTIVE INGREDIENTS (1)
LINAGLIPTINActive
Strength: 5 MG
Monograph: LINAGLIPTIN